title: [Combined application of magnetolaserotherapy and polyunsaturated fatty acids for the treatment of patients with hypertensive disease].
abstract: The authors report the results of combined treatment including application of magnetolaserotherapy and n-3 polyunsaturated fatty acids for the management of patients presenting with hypertensive disease. These data give evidence of the accumulation of atherogenic fractions of plasma lipids and pathological modification of the fatty acid composition in erythrocyte membranes. They suggest the appropriateness of lipid-correcting and membrane-protective treatment for patients presenting with hypertensive disease. It is concluded that the proposed combination of magnetolaserotherapy and polyunsaturated fatty acids may be instrumental in the normalization of the serum lipid profile and the correction of the cellular fatty acid composition.
authors.forename: M V
authors.initials: MV
authors.lastname: Antoniuk
authors.forename: T A
authors.initials: TA
authors.lastname: Kantur
authors.forename: Iu K
authors.initials: IuK
authors.lastname: Karaman
authors.forename: N V
authors.initials: NV
authors.lastname: Zhukova
mesh_terms: D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D003131:Combined Modality Therapy; D019587:Dietary Supplements; D004912:Erythrocytes / Q000187:drug effects / Q000378:metabolism; D015525:Fatty Acids, Omega-3 / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000378:metabolism / Q000532:radiotherapy / Q000534:rehabilitation*; D008055:Lipids / Q000097:blood; D028022:Low-Level Light Therapy / Q000379:methods*; D055909:Magnetic Field Therapy / Q000379:methods*; D008297:Male; D008563:Membrane Lipids / Q000378:metabolism; D008875:Middle Aged; D016896:Treatment Outcome
chemical_list: D015525:Fatty Acids, Omega-3; D008055:Lipids; D008563:Membrane Lipids